CSP Inc. Q2 net income surges to $1.6M; services revenue up 23%, gross margin expands to 47%

CSP INC /MA/

2024-Q2 EPS reported $0.15 revenue$29,081,000

Net income $1.6M ($0.16 diluted EPS) vs $0.3M ($0.03) a year ago, nearly five-fold increase.
Revenue $13.7M, up slightly from $13.3M; services revenue grew 23% to $5.2M.
Gross margin improved to 47% from 38% on higher-margin services and AZT sale.
Board declared $0.03 quarterly dividend, payable June 12 to holders of record May 24.
Global pharmaceutical company signed multi-million dollar AZT PROTECT contract; AZT launch expanded to mid-market.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CSP INC /MA/ reported fiscal second quarter ended March 31, 2024 results: revenue $13.7 million, net income $1.6 million, EPS $0.16 per diluted common share.

Period: fiscal second quarter ended March 31, 2024
Revenue: $13.7 million
Net income: $1.6 million
EPS: $0.16 per diluted common share
Result: reported results

Exact text from the filing

Revenue for the fiscal second quarter ended March 31, 2024, was up slightly to $13.7 million compared to revenue of $13.3 million for the fiscal second quarter ended March 31, 2023.

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

CSP INC /MA/ filing history →

Source: SEC EDGAR

accession 0000356037-24-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.